138 related articles for article (PubMed ID: 32202954)
1. Some sulfonamides as aldose reductase inhibitors: therapeutic approach in diabetes.
Demir Y; Köksal Z
Arch Physiol Biochem; 2022 Aug; 128(4):979-984. PubMed ID: 32202954
[TBL] [Abstract][Full Text] [Related]
2. Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney.
Demir Y; Işık M; Gülçin İ; Beydemir Ş
J Biochem Mol Toxicol; 2017 Sep; 31(9):. PubMed ID: 28557170
[TBL] [Abstract][Full Text] [Related]
3. Anti-diabetic Properties of Calcium Channel Blockers: Inhibition Effects on Aldose Reductase Enzyme Activity.
Türkeş C; Demir Y; Beydemir Ş
Appl Biochem Biotechnol; 2019 Sep; 189(1):318-329. PubMed ID: 30980289
[TBL] [Abstract][Full Text] [Related]
4. N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors.
Türkeş C; Arslan M; Demir Y; Çoçaj L; Nixha AR; Beydemir Ş
J Mol Recognit; 2022 Dec; 35(12):e2991. PubMed ID: 36073557
[TBL] [Abstract][Full Text] [Related]
5. Antidiabetic properties of dietary phenolic compounds: Inhibition effects on α-amylase, aldose reductase, and α-glycosidase.
Demir Y; Durmaz L; Taslimi P; Gulçin İ
Biotechnol Appl Biochem; 2019 Sep; 66(5):781-786. PubMed ID: 31135076
[TBL] [Abstract][Full Text] [Related]
6. Inhibition effects of quinones on aldose reductase: Antidiabetic properties.
Demir Y; Özaslan MS; Duran HE; Küfrevioğlu Öİ; Beydemir Ş
Environ Toxicol Pharmacol; 2019 Aug; 70():103195. PubMed ID: 31125830
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and aldose reductase inhibition effects of celecoxib derivatives containing pyrazole linked-sulfonamide moiety.
Bayrak C
Bioorg Chem; 2022 Nov; 128():106086. PubMed ID: 35973306
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
Sever B; Altıntop MD; Demir Y; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
[TBL] [Abstract][Full Text] [Related]
9. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
Sever B; Altıntop MD; Demir Y; Yılmaz N; Akalın Çiftçi G; Beydemir Ş; Özdemir A
Chem Biol Interact; 2021 Aug; 345():109576. PubMed ID: 34252406
[TBL] [Abstract][Full Text] [Related]
10. Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia.
Taslimi P; Aslan HE; Demir Y; Oztaskin N; Maraş A; Gulçin İ; Beydemir S; Goksu S
Int J Biol Macromol; 2018 Nov; 119():857-863. PubMed ID: 30077669
[TBL] [Abstract][Full Text] [Related]
11. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
[TBL] [Abstract][Full Text] [Related]
12. Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus.
Kousaxidis A; Petrou A; Lavrentaki V; Fesatidou M; Nicolaou I; Geronikaki A
Eur J Med Chem; 2020 Dec; 207():112742. PubMed ID: 32871344
[TBL] [Abstract][Full Text] [Related]
13. A new series of hydrazones as small-molecule aldose reductase inhibitors.
Altıntop MD; Demir Y; Türkeş C; Öztürk RB; Cantürk Z; Beydemir Ş; Özdemir A
Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200570. PubMed ID: 36603162
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of Isoflavones isolated from Caesalpinia pulcherrima on aldose reductase in STZ induced diabetic rats.
Kumar MP; Sankeshi V; Naik RR; Thirupathi P; Das B; Raju TN
Chem Biol Interact; 2015 Jul; 237():18-24. PubMed ID: 25986969
[TBL] [Abstract][Full Text] [Related]
15. Designing of acyl sulphonamide based quinoxalinones as multifunctional aldose reductase inhibitors.
Ji Y; Chen X; Chen H; Zhang X; Fan Z; Xie L; Ma B; Zhu C
Bioorg Med Chem; 2019 Apr; 27(8):1658-1669. PubMed ID: 30858026
[TBL] [Abstract][Full Text] [Related]
16. Novel spiroindoline derivatives targeting aldose reductase against diabetic complications: Bioactivity, cytotoxicity, and molecular modeling studies.
Güleç Ö; Türkeş C; Arslan M; Demir Y; Dincer B; Ece A; İrfan Küfrevioğlu Ö; Beydemir Ş
Bioorg Chem; 2024 Apr; 145():107221. PubMed ID: 38387398
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol.
Sampath C; Sang S; Ahmedna M
Biomed Pharmacother; 2016 Dec; 84():502-513. PubMed ID: 27685794
[TBL] [Abstract][Full Text] [Related]
18. Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and α-glycosidase and molecular docking studies.
Demir Y; Taslimi P; Koçyiğit ÜM; Akkuş M; Özaslan MS; Duran HE; Budak Y; Tüzün B; Gürdere MB; Ceylan M; Taysi S; Gülçin İ; Beydemir Ş
Arch Pharm (Weinheim); 2020 Dec; 353(12):e2000118. PubMed ID: 32761859
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of capsaicin inhibition of aldose reductase activity.
Alim Z; Kilinc N; Sengul B; Beydemir S
J Biochem Mol Toxicol; 2017 Jul; 31(7):. PubMed ID: 28217947
[TBL] [Abstract][Full Text] [Related]
20. Aldose reductase inhibition of a saponin-rich fraction and new furostanol saponin derivatives from Balanites aegyptiaca.
Abdel Motaal A; El-Askary H; Crockett S; Kunert O; Sakr B; Shaker S; Grigore A; Albulescu R; Bauer R
Phytomedicine; 2015 Aug; 22(9):829-36. PubMed ID: 26220630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
